High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction - PubMed (original) (raw)
. 2003 May 9;278(19):16608-13.
doi: 10.1074/jbc.M208435200. Epub 2003 Feb 11.
Affiliations
- PMID: 12582176
- DOI: 10.1074/jbc.M208435200
Free article
High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction
Michael P Malakhov et al. J Biol Chem. 2003.
Free article
Abstract
ISG15 is a ubiquitin-like protein that conjugates to numerous proteins in cells treated with interferon or lipopolysaccharide. Dysregulation of protein ISG15 modification (ISGylation) in mice leads to decreased life expectancy, brain cell injury, and hypersensitivity to interferon. Although ISG15 was identified more than two decades ago, the exact biochemical and physiological functions of ISG15-modification remain unknown, and the proteins targeted by ISG15 have not been identified. The major purpose of this work was to identify ISG15 targets among well characterized proteins that could be used as models for biological studies. We purified ISGylated proteins from human thymus by immunoaffinity chromatography and analyzed ISG15 conjugates by a high-throughput Western blot screen (PowerBlot). We found that three key regulators of signal transduction, phospholipase Cgamma1, Jak1, and ERK1 are modified by ISG15. In addition to that, we demonstrate that transcription factor Stat1, an immediate substrate of Jak1 kinase, is also ISGylated. Using whole cell protein extracts and phospholipase Cgamma1 as an example we demonstrate that ISG15 conjugates are not accumulated in cells treated with specific inhibitors of proteasomes. Our work suggests a role for ISG15 in the regulation of multiple signal transduction pathways and offers attractive models to further elucidate the biochemical function of ISGylation.
Similar articles
- Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.
Kim KI, Giannakopoulos NV, Virgin HW, Zhang DE. Kim KI, et al. Mol Cell Biol. 2004 Nov;24(21):9592-600. doi: 10.1128/MCB.24.21.9592-9600.2004. Mol Cell Biol. 2004. PMID: 15485925 Free PMC article. - Consecutive Inhibition of ISG15 Expression and ISGylation by Cytomegalovirus Regulators.
Kim YJ, Kim ET, Kim YE, Lee MK, Kwon KM, Kim KI, Stamminger T, Ahn JH. Kim YJ, et al. PLoS Pathog. 2016 Aug 26;12(8):e1005850. doi: 10.1371/journal.ppat.1005850. eCollection 2016 Aug. PLoS Pathog. 2016. PMID: 27564865 Free PMC article. - ISG15, not just another ubiquitin-like protein.
Kim KI, Zhang DE. Kim KI, et al. Biochem Biophys Res Commun. 2003 Aug 1;307(3):431-4. doi: 10.1016/s0006-291x(03)01216-6. Biochem Biophys Res Commun. 2003. PMID: 12893238 Review. - Proteomic identification of proteins conjugated to ISG15 in mouse and human cells.
Giannakopoulos NV, Luo JK, Papov V, Zou W, Lenschow DJ, Jacobs BS, Borden EC, Li J, Virgin HW, Zhang DE. Giannakopoulos NV, et al. Biochem Biophys Res Commun. 2005 Oct 21;336(2):496-506. doi: 10.1016/j.bbrc.2005.08.132. Biochem Biophys Res Commun. 2005. PMID: 16139798 - ISG15 and immune diseases.
Jeon YJ, Yoo HM, Chung CH. Jeon YJ, et al. Biochim Biophys Acta. 2010 May;1802(5):485-96. doi: 10.1016/j.bbadis.2010.02.006. Epub 2010 Feb 12. Biochim Biophys Acta. 2010. PMID: 20153823 Free PMC article. Review.
Cited by
- ABCG2 shields against epilepsy, relieves oxidative stress and apoptosis via inhibiting the ISGylation of STAT1 and mTOR.
Li C, Cai Y, Chen Y, Tong J, Li Y, Liu D, Wang Y, Li Z, Wang Y, Li Q. Li C, et al. Redox Biol. 2024 Sep;75:103262. doi: 10.1016/j.redox.2024.103262. Epub 2024 Jul 4. Redox Biol. 2024. PMID: 38981367 Free PMC article. - The ISG15-Protease USP18 Is a Pleiotropic Enhancer of HIV-1 Replication.
Lin C, Kuffour EO, Li T, Gertzen CGW, Kaiser J, Luedde T, König R, Gohlke H, Münk C. Lin C, et al. Viruses. 2024 Mar 22;16(4):485. doi: 10.3390/v16040485. Viruses. 2024. PMID: 38675828 Free PMC article. Review. - Interferons and interferon-related pathways in heart disease.
Tran DT, Batchu SN, Advani A. Tran DT, et al. Front Cardiovasc Med. 2024 Apr 11;11:1357343. doi: 10.3389/fcvm.2024.1357343. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38665231 Free PMC article. Review. - Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways.
Wang R, He S, Long J, Wang Y, Jiang X, Chen M, Wang J. Wang R, et al. Exp Hematol Oncol. 2024 Apr 23;13(1):46. doi: 10.1186/s40164-024-00515-5. Exp Hematol Oncol. 2024. PMID: 38654302 Free PMC article. Review. - Chemical tools to define and manipulate interferon-inducible Ubl protease USP18.
Davis GJ, Omole AO, Jung Y, Rut W, Holewinski R, Suazo KF, Kim HR, Yang M, Andresson T, Drag M, Yoo E. Davis GJ, et al. bioRxiv [Preprint]. 2024 Apr 8:2024.04.08.588544. doi: 10.1101/2024.04.08.588544. bioRxiv. 2024. PMID: 38645224 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous